.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Chubb
Farmers Insurance
Johnson and Johnson
US Department of Justice
Deloitte
Cerilliant
Fish and Richardson
US Army
AstraZeneca

Generated: November 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018297

« Back to Dashboard
NDA 018297 describes LOPURIN, which is a drug marketed by Dr Reddys La and Abbott and is included in three NDAs. It is available from seven suppliers. Additional details are available on the LOPURIN profile page.

The generic ingredient in LOPURIN is allopurinol. There are twenty-one drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the allopurinol profile page.

Summary for 018297

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antigout Agents
Formulation / Manufacturing:see details

Medical Subject Heading (MeSH) Categories for 018297

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength100MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength300MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Expired Orange Book Patents for NDA: 018297

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbott
LOPURIN
allopurinol
TABLET;ORAL018297-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Abbott
LOPURIN
allopurinol
TABLET;ORAL018297-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
US Army
Cerilliant
Johnson and Johnson
Dow
Daiichi Sankyo
Citi
Novartis
Argus Health
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot